Global Life Sciences


INDEXFirstLastClimberFaller
2021 Q1 Apotex Taro Pharmaceutical Industries Nova Nordisk UK (+107) Vernalis (-84)
2020 Q4 Medivir Group Taro Pharmaceutical Industries Kaneka (+156) Bargn Farmaceutici (-97)
2020 Q3 Apotex Pfizer Taisho Pharmaceutical (+86) Piramel Enterprises (-132)
2020 Q2 Apotex Handok Alexion Pharmaceuticals (+79) Array BioPharma (-159)
2020 Q1 Apotex Taro Pharmaceutical Industries Sawai Pharmaceutical (+77) Piramel Enterprises (-97)
2019 Q4 Cytogen Taro Pharmaceutical Industries Biogen Idec (+108) QLT (-104)
2019 Q3 Cytogen Taro Pharmaceutical Industries Purdue Pharma (+154) EISAI (-103)
2019 Q2 Pfizer UK Taro Pharmaceutical Industries Patheon (+136) Meda Pharmaceuticals (-161)
2019 Q1 Cytogen Taro Pharmaceutical Industries Baxter International (+138) BTG International (-174)
2018 Q4 Cytogen Taro Pharmaceutical Industries Advaxis (+128) Baxter International (-112)
2018 Q3 Cytogen Taro Pharmaceutical Industries Medivir Group (+121) Akorn (-102)
2018 Q2 Cytogen Perrigo UK Sanofi (+175) Advaxis (-106)
2018 Q1 HG Capital Trust Perrigo UK Genus (+153) Sawai Pharmaceutical (-131)
2017 Q4 HG Capital Trust Cerus Zandu (+104) Aptalis Pharma (-101)
2017 Q3 Servier UK Perrigo UK Leo Pharma UK (+86) Chiesi (-125)
2017 Q2 Servier UK Myriad Genetics Bosnalijek (+196) Anika Therapeutics (-175)
2017 Q1 Servier UK Sinovac Biotech Regeneron (+130) Bosnalijek (-112)
2016 Q4 Taisho Pharmaceutical Sinovac Biotech MannKind Corporation (+172) CinnaGen (-201)
2016 Q3 Wockhardt Sinovac Biotech Biota (+134) Daiichi-Sankyo UK (-98)
2016 Q2 ProStrakan Group Santen Europe Julphar (+185) Alfa Wassermann (-131)
2016 Q1 Neurocrine Biosciences Enzon Pharmaceuticals Cipla (+157) Laboratoires Thea (-127)
2015 Q4 Anika Therapeutics Sinopharm Baxter International (+168) ImmunoGen (-123)
2015 Q3 Anika Therapeutics Beximco Pharmaceuticals Dr Reddy's (+150) Progenics Pharmaceuticals (-75)
2015 Q2 Actelion Sinopharm Anika Therapeutics (+187) Mylan (-157)
2015 Q1 Biogen Idec Sinopharm NPS Pharmaceuticals (+133) Hospira UK (-149)
2014 Q4 Biogen Idec Sinopharm Bial Portela (+117) Genus (-124)
2014 Q3 Biogen Idec Sinopharm Mitsubishi Tanabe Pharma Europe Ltd (+207) Questcor (-210)
2014 Q2 Cytogen Merck Sharp & Dohme, MSD Medivation (+122) Idenix Pharmaceuticals (-222)
2014 Q1 Idenix Pharmaceuticals Sinopharm Advaxis (+167) Celgene (-114)
2013 Q4 Idenix Pharmaceuticals Sinopharm Intas Biopharmaceuticals (+132) Sawai Pharmaceutical (-160)
2013 Q3 Idenix Pharmaceuticals Sinopharm ImmunoGen (+164) ARIAD Pharmaceuticals (-140)
2013 Q2 Galenica AG Sinopharm Ferozsons Laboratories (+54) Hospira (-180)
2013 Q1 Siegfried AG Sinopharm Group Perrigo (+82) Alkaloid (-77)
2012 Q4 NovImmune Sinopharm Group Takeda Pharma AG (+125) Ego Pharmaceuticals (-116)
2012 Q3 NovImmune Sinopharm Group GenKyoTex SA (+147) Genzyme (-90)
2012 Q2 Cilag AG Sinopharm Group LEO Pharmaceutical Products Sarath Ltd. (+122) Sanofi-Aventis (-116)
2012 Q1 Cilag AG Sinopharm Group Wockhardt (+196) Johnson & Johnson Pharmaceutical Research & Development (-90)
2011 Q4 Anergis Sinopharm Group Schwabe Pharma AG (+93) Nitec Pharma AG (-120)
2011 Q3 Cilag AG Baxter Switzerland Neurim Pharmaceuticals S.A. (+94) Nycomed Pharma AG (-69)
2011 Q2 Siegfried AG Baxter Switzerland MEDA Pharma GmbH (+59) Arpida AG (-41)
2011 Q1 Cilag AG Neurim Pharmaceuticals S.A. Antares Pharma AG (+33) F. Hoffmann-La Roche AG (Worldwide) (-58)
2010 Q3 Neurimmune Therapeutics AG Helsinn Healthcare S.A. Med Discovery S.A. (+39) Lipideon Biotechnology AG (-23)
2010 Q2 Neurimmune Therapeutics AG Helsinn Healthcare S.A. F. Hoffmann-La Roche AG Global (+54) Helsinn Healthcare S.A. (-73)
2010 Q1 Neurimmune Therapeutics AG OM PHARMA Medinova AG (+57) PharmaSwiss SA - HQ (-39)
2009 Q4 Neurimmune Therapeutics AG OM PHARMA